Fenocap

LIPID LOWERING DRUGS: Fenofibrate

Indication

Fenofibrate (Fenocap) is indicated for hyperlipidemias of type IIa, IIb, III, IV & V in patients who have not responded adequately to diet & other appropriate measures. 

Contraindication

Fenofibrate (Fenocap) is contraindicated in patients with hypersensitivity to Fenofibrate (Fenocap) , severe renal or hepatic impairment, existing gall bladder disease, breast feeding mothers, photosensitivity to ketoprofen.

 

Dosage & Administration

Fenofibrate (Fenocap) capsule 200 mg once daily is recommended as the dose for the treatment of primary hypercholesterolemia, hypertriglyceridemia or mixed hyperlipidemia. Absorption of Fenofibrate (Fenocap)  is increased by approximately 35% when administered with food.

Side Effect

Gastro-intestinal (e.g. nausea, anorexia, and gastric pain), pruritus, urticaria, impotence, headache, dizziness, vertigo, fatigue, hair loss, myotoxicity.

Drug Interaction

Fenocap (Fenofibrate) has been reported to potentiate the anticoagulant effects of warfarin. Also Fenofibrate (Fenocap) may increase the nephrotoxicity of cyclosporine. Due to a potential increase the risk of rhabdomyolysis, cautions should be taken against the use of Fenofibrate (Fenocap) with HMG-CoA reductase inhibitors unless the benefits outweigh the risks. However, the use of low-dose statins with Fenofibrate (Fenocap) appears to be well tolerated.

Presentation

Fenocap Capsule: Each box containing 3×14\\\’s capsules in blister pack.